A bill to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.

S. 4027, the "Healthy Competition for Better Care Act," directly amends Section 2799A-9 of the Public Health Service Act. This amendment prohibits group health plans and health insurance issuers from entering into agreements that restrict directing patients to other providers, offering incentives for specific providers, requiring additional agreements with affiliates, or preventing lower rates for other plans. This bill targets specific contractual terms that currently limit competition and inflate healthcare costs. The immediate impact is a shift in power dynamics within the healthcare ecosystem, favoring insurers and health plans. The money trail indicates a direct benefit to health insurance companies. By eliminating restrictions on steering patients and negotiating rates, insurers can more effectively manage their networks and reduce costs. This translates to improved profitability for companies like UnitedHealth Group ($UNH), Elevance Health, Humana ($HUM), CVS Health ($CVS) through its Aetna subsidiary, and Cigna ($CI). Conversely, large hospital systems and provider groups that rely on restrictive contracts to maintain market share and pricing power will face increased pressure. Companies such as HCA Healthcare ($HCA) and other large hospital chains will experience reduced leverage in contract negotiations. Historically, legislative efforts to increase competition in healthcare have led to shifts in market valuations. For example, the No Surprises Act, enacted in December 2020, aimed to protect consumers from unexpected medical bills and introduced new billing dispute resolution processes. While not directly comparable in scope, it signaled a regulatory trend towards greater transparency and consumer protection, which generally benefits insurers by reducing unexpected costs. Following the passage of the No Surprises Act, major health insurers like UnitedHealth Group ($UNH) saw a steady increase in stock price, with $UNH rising approximately 15% in the six months following its enactment, as the market anticipated improved cost management. Specific winners include major health insurers: UnitedHealth Group ($UNH), Elevance Health, Humana ($HUM), CVS Health ($CVS), and Cigna ($CI). These companies gain significant negotiation power and flexibility in network design. Specific losers include large hospital systems and provider groups that have historically benefited from anticompetitive clauses, such as HCA Healthcare ($HCA), Centene ($CNC), and Molina Healthcare ($MOH), as their ability to dictate terms and maintain high rates diminishes. The bill was introduced by Senator Husted, a Republican, indicating bipartisan potential for market-oriented healthcare reforms, though it is currently referred to committee. Next steps involve committee consideration in the Senate Committee on Health, Education, Labor, and Pensions. If it passes committee, it proceeds to a full Senate vote. The timeline for passage is uncertain, but the introduction signals a clear intent to address healthcare competition. If enacted, the changes would take effect upon signing, immediately altering contractual landscapes in the healthcare sector.